Form 4: Zura Bio Director Amit Munshi Acquires Options in Company

Director Amit Munshi reports acquisition of share options in Zura Bio Ltd.

Summary

• On May 21, 2025, Amit Munshi, a director of Zura Bio Ltd, acquired 51,000 share options with an exercise price of $1.03.
• The options vest in twelve equal monthly installments over one year from the grant date, with any remaining unvested portion vesting before the next annual shareholder meeting, contingent on continued service.
• Following the transaction, Munshi directly owns 51,000 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing indicating an insider transaction. The acquisition of options is generally viewed positively, but it's not a major event.

Positives

• The acquisition of share options by a director signals confidence in the company's future prospects.

Future Outlook

The vesting schedule suggests a continued commitment from the director to the company's long-term success.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which can influence investor sentiment.

Stakeholder Impact

• The transaction provides shareholders with insight into the director's stake in the company.

Key Dates

Keywords

Zura Bio Ltd, share options, director, Amit Munshi, Form 4, beneficial ownership, equity securities